Paid Clinical Trials in Newark, DE
As of July 2026, 172 paid clinical trials are recruiting in Newark, Delaware. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Newark offers studies at sites including Helen F Graham Cancer Center for conditions such as Breast Cancer, Anatomic Stage II Breast Cancer AJCC v8, Multiple Myeloma, Malignant Solid Neoplasm. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Newark
Trials by drug in Newark
Filter results
165 clinical trials
↓ Download CSVMammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Previously Untreated Follicular Lymphoma
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
A Study to Evaluate the Safety and Efficacy of BGB-16673 Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast
A Study Comparing Talquetamab Plus Pomalidomide, Talquetamab Plus Teclistamab, and Elotuzumab, Pomalidomide, and Dexamethasone or Pomalidomide, Bortezomib, and Dexamethasone in Participants With Relapsed or Refractory Myeloma Who Have Received an Anti-CD38 Antibody and Lenalidomide
Strategy for Improving Stroke Treatment Response
A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion
A Study of Patients With Lower Extremity Acute Limb Ischemia to Remove Thrombus With the Indigo™ Aspiration System (STRIDE II)
Study of the Long-Term Safety and Outcomes of Treating Pulmonary Embolism With the Indigo Aspiration System
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer
A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib Studies
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
Study of SGR-1505 in Mature B-Cell Neoplasms
Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors
Non-Invasive Preeclampsia Screening and Biobank
Human Menopausal Gonadotropin Research in Infertility Assessing Cumulative Live Birth With Frozen Embryo Transfer.
Deep Neural Network Stratification for Use Detecting Endometriosis in Women Affected by Chronic Pelvic Pain (EndoCheck)
About research studies in Newark
Newark has approximately 172 recruiting research studies across a wide range of therapeutic areas. Delaware hosts a diverse network of universities, academic medical centers, and community hospitals that run clinical trials across oncology, cardiology, neurology, and many other therapeutic areas.
Top Research Study Locations in Newark
Researchers run research studies in Newark, DE at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Helen F Graham Cancer Center | Anatomic Stage II Breast Cancer AJCC v8, Malignant Solid Neoplasm, Stage IIIB Lung Cancer AJCC v8 | 73 |
| Medical Oncology Hematology Consultants PA | Anatomic Stage II Breast Cancer AJCC v8, Malignant Solid Neoplasm, Stage IIIB Lung Cancer AJCC v8 | 68 |
| Christiana Care Health System-Christiana Hospital | Malignant Solid Neoplasm, Stage IIIB Lung Cancer AJCC v8, Stage IV Lung Cancer AJCC v8 | 43 |
| Delaware Clinical and Laboratory Physicians PA | Malignant Solid Neoplasm, Metastatic Malignant Neoplasm in the Brain, Stage IIIB Lung Cancer AJCC v8 | 19 |
| University of Delaware | Hypertension, Major Depressive Disorder, Parkinson Disease | 15 |
| Christiana Care | Advanced Colorectal Cancer, Autism Spectrum Disorder, Blood Loss, Surgical | 7 |
| Medical Oncology Hematology Consultants, PA | Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Leukemia, Myeloid, Acute | 7 |
| Medical Oncology Hematology Consultants | Advanced Malignant Neoplasm, Advanced Solid Tumor, Breast Cancer | 6 |
| Christiana Care Health Services | Advanced Cancer, Advanced or Metastatic Solid Tumor, Cardiovascular Diseases | 5 |
| Christiana Care Health Services, Inc. | Acute Myocardial Infarction, Acute Myocardial Infarction (AMI), Cardiovascular Risk | 4 |
| Christiana Hospital | Idiopathic Pulmonary Fibrosis, Ischemic Stroke, Progressive Pulmonary Fibrosis | 3 |
| ChristianaCare Health System | Abnormal Uterine Bleeding, Unspecified, Adenomyosis of Uterus, Adnexal Diseases | 2 |
| ChristianaCare Helen F Graham Cancer Center and Research Institute | Carcinoma, Non-Small-Cell Lung, Multiple Myeloma | 2 |
| Medical Oncology Hematology Consultants Helen F Graham Cancer Center | Metastatic Castration-resistant Prostate Cancer, Non-Small Cell Lung Cancer (NSCLC) | 2 |
| Medical Oncology Hematology Consultants (MOHC) | Breast Neoplasms, Lymphoma, Large B-Cell, Diffuse | 2 |
| Christiana Care Health Service | Follicular Lymphoma (FL) | 1 |
| Christiana Care Health System - Newark | Solid Tumor | 1 |
| Christiana Care Helen F. Graham Cancer Center | Cancer | 1 |
| Christiana Care Hospital | Pulmonary Embolism | 1 |
| Christiana Care Hospital - Helen F Graham Cancer Center | ALK-Positive Large B-Cell Lymphoma, Burkitt Lymphoma, Chronic Lymphocytic Leukemia | 1 |
| Christiana Care/New Castle County EMS | Congestive Heart Failure(CHF), Pulmonary Edema | 1 |
| Christiana Surgicenter | Lumbar Spinal Stenosis | 1 |
| ChristianaCare | Delivery Room Resuscitation, Implementation Research, Infant, Newborn | 1 |
| ChristianaCare Health Services, Inc. | PreTerm Neonate, Respiratory Distress Syndrome (RDS) | 1 |
| ChristianaCare-Helen F. Graham Cancer Center & Research Institute | Breast Cancer Screening, Colon Cancer Screening, Genetics Predisposition | 1 |
Active & Upcoming Studies in Newark (2026)
Recruiting trials in Newark grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (109 active studies)
- Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial · Phase 3 · National Cancer Institute (NCI)
- Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations · Phase 3 · SWOG Cancer Research Network
Neurology & pain (8 active studies)
- Cyclobenzaprine for Postoperative Pain in Minimally Invasive Hysterectomy · Phase 4 · Christiana Care Health Services
- Pain and Split-belt Motor Learning in Older Adults · University of Delaware
Cardiovascular (4 active studies)
- Evaluating the Use of Prehospital Lung Ultrasound in EMS: A Multicenter Pilot Study · Rutgers, The State University of New Jersey
- Examining the Circadian Timing Effects of the Hypotensive Response to Exercise · Freda Patterson
Diabetes & metabolic (2 active studies)
- DECIDE: A Comparative Effectiveness Trial of Metformin Versus Insulin for the Treatment of Gestational Diabetes · Phase 4 · Ohio State University
- Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease · Phase 3 · Prokidney
Pediatric (2 active studies)
- Supraglottic Airway for Resuscitation Trial · Children's Hospital of Philadelphia
- Study of SGR-1505 in Mature B-Cell Neoplasms · Phase 1 · Schrödinger, Inc.
Vaccines (1 active study)
HIV / STI (1 active study)
Common conditions studied in Newark
- Breast Cancer (6 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
- Anatomic Stage II Breast Cancer AJCC v8 (5 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
- Multiple Myeloma (5 active studies). Recruiting Multiple Myeloma studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Malignant Solid Neoplasm (4 active studies). Recruiting Malignant Solid Neoplasm studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Stage IIIB Lung Cancer AJCC v8 (4 active studies). Lung cancer research focuses on targeted therapies for specific mutations such as EGFR, ALK, and KRAS, alongside immunotherapy regimens.
- Stage IV Lung Cancer AJCC v8 (4 active studies). Lung cancer research focuses on targeted therapies for specific mutations such as EGFR, ALK, and KRAS, alongside immunotherapy regimens.
Leading research sponsors in Newark
- National Cancer Institute (NCI)
- University of Delaware
- Alliance for Clinical Trials in Oncology
- NRG Oncology
- AstraZeneca
Local regulations and guidelines
Clinical trials in Delaware are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. Delaware research additionally follows state public health department oversight and any applicable state privacy statutes.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in Newark. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in Newark
Hipa.ai aggregates every recruiting study in Newark from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in Newark?
There are approximately 172 recruiting clinical trials in Newark, Delaware listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Newark pay participants?
Most recruiting trials in Newark compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Newark?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Newark?
The most common conditions under active study in Newark include Breast Cancer (6), Anatomic Stage II Breast Cancer AJCC v8 (5), Multiple Myeloma (5), Malignant Solid Neoplasm (4), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Newark?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Newark on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Newark?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Newark?
Recruiting research sites in Newark include Helen F Graham Cancer Center, Medical Oncology Hematology Consultants PA, Christiana Care Health System-Christiana Hospital, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Newark right now?
The largest active categories in Newark are Cancer & tumors (109), Neurology & pain (8), Cardiovascular (4). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.